These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36350127)

  • 1. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
    Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity.
    Akorli J; Opoku M; Appiah-Twum F; Akpo MS; Ismail RY; Boamah GYK; Obeng-Aboagye E; Adu-Asamoah D; Donkor IO
    BMC Infect Dis; 2024 Sep; 24(1):1020. PubMed ID: 39304808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
    Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
    Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Naso-Oropharyngeal Bacterial Composition in Suspected SARS-CoV-2 Cases.
    Atencio LA; Quintero IJ; Almanza A; Eskildsen G; Sánchez-Gallego J; Herrera M; Fernández-Marín H; Loaiza JR; Mejía LC
    Pathogens; 2024 Jul; 13(8):. PubMed ID: 39204216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    Wu J; Liu W; Zhu L; Li N; Luo G; Gu M; Peng M; Zeng S; Wu S; Zhang S; Chen Q; Cai M; Cao W; Jiang Y; Luo C; Tian D; Shi M; Shu Y; Chang G; Luo H
    J Med Virol; 2023 Apr; 95(4):e28727. PubMed ID: 37185870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of oropharyngeal microbiota in healthcare workers post-COVID-19.
    Wei Y; Yu W; Zhang Z; Liu S; Xue J; Wu C; Gao Z; Guo S
    Front Cell Infect Microbiol; 2024; 14():1347345. PubMed ID: 38828262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.
    Ma S; Zhang F; Zhou F; Li H; Ge W; Gan R; Nie H; Li B; Wang Y; Wu M; Li D; Wang D; Wang Z; You Y; Huang Z
    Signal Transduct Target Ther; 2021 May; 6(1):191. PubMed ID: 33986253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.
    Rueca M; Fontana A; Bartolini B; Piselli P; Mazzarelli A; Copetti M; Binda E; Perri F; Gruber CEM; Nicastri E; Marchioni L; Ippolito G; Capobianchi MR; Di Caro A; Pazienza V
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
    Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
    Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections.
    Zhou Y; Lu S; Wei X; Hu Y; Li H; Wang J; Lin Y; Li M; Wang M; Ma J; Zhu Z; Yang S; Ying B; Zhang W; Chen B; Li W
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
    Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
    Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.
    Gao M; Wang H; Luo H; Sun Y; Wang L; Ding S; Ren H; Gang J; Rao B; Liu S; Wang X; Gao X; Li M; Zou Y; Liu C; Yuan C; Sun J; Cui G; Ren Z
    Adv Sci (Weinh); 2021 Oct; 8(20):e2102785. PubMed ID: 34423593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity].
    Starikova EV; Galeeva JS; Andreev DN; Sokolov PS; Fedorov DE; Manolov AI; Pavlenko AV; Klimina KM; Veselovsky VA; Zaborovsky AV; Evdokimov VV; Andreev NG; Devkota MK; Fomenko AK; Khar'kovskii VA; Asadulin PO; Kucher SA; Cheremushkina AS; Yanushevich OO; Maev IV; Krikheli NI; Levchenko OV; Ilina EN; Govorun VM
    Ter Arkh; 2022 Oct; 94(8):963-972. PubMed ID: 36286976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency.
    Pulvirenti F; Giufrè M; Pentimalli TM; Camilli R; Milito C; Villa A; Sculco E; Cerquetti M; Pantosti A; Quinti I
    Front Immunol; 2024; 15():1371118. PubMed ID: 38873612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.